# Notice of Intent to Grant Exclusive Patent License; American BioHealth Group, LLC
**AGENCY:**
Department of the Navy, DOD.
**ACTION:**
Notice.
**SUMMARY:**
The Department of the Navy hereby gives notice of its intent to grant to American BioHealth Group, LLC, a revocable, nonassignable, exclusive license in the United States to practice, with right to sublicense, the Government-owned invention described in U.S. Patent No. 6,177,434, entitled “Prevention or Reversal of Sensorial Hearing Loss Through Biological Mechanisms,” issued January 23, 2001, Navy Case No. 78,564.
**DATES:**
Anyone wishing to object to the granting of this license has (15) days from the date of this notice to file written objections along with supporting evidence, if any.
**ADDRESSES:**
Written objections are to be filed with the Office of Naval Research, ONR 00CC, Ballston Tower One, 800 North Quincy St., Arlington, VA 22217-5660.
**FOR FURTHER INFORMATION CONTACT:**
Mr. A. David Spevack, Supervisory Associate Counsel, Intellectual Property, Office of Naval Research, ONR 00CC, Ballston Tower One, 800 North Quincy St., Arlington, VA 22217-5660, telephone (703) 696-4007, E-Mail *[email protected]* or fax (703) 696-6909.
(Authority: 35 U.S.C. 207, 37 CFR Part 404)
Dated: January 15, 2002.
T.J. Welsh,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.